Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other service sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.…
Aimei Health Technology (NASDAQ: AFJK) is listed on Nasdaq, where its shares trade in USD. It belongs to the Shell Companies industry, part of the Financial Services sector.
The shares were at 11.78 USD on 20 November 2026, up 4.0% over 52 weeks. Its 52-week range is 6.750 USD to 130.37 USD: the price is 91.0% below the high and 74.5% above the low.
Its market capitalisation is 37.30M USD.
Aimei Health Technology reports return on equity of 13.2% and an operating margin of 0.0%.
Its debt exceeds its cash by 3.81M USD, a debt-to-equity ratio of 0.25. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.
No upcoming events tracked.